TY - JOUR
T1 - Strengthening national vaccine decision-making
T2 - Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries
AU - van Zandvoort, Kevin
AU - Howard, Natasha
AU - Mounier-Jack, Sandra
AU - Jit, Mark
N1 - Publisher Copyright:
© 2018 The Authors
PY - 2019/1/14
Y1 - 2019/1/14
N2 - Background: National Immunisation Technical Advisory Groups (NITAGs) are multi-disciplinary expert groups that provide policy-makers with independent, evidence-based advice on vaccination. Between 2008 and 2017, the SIVAC Initiative supported establishment and strengthening of NITAGs in low and lower-middle income countries though its impact was never assessed quantitatively. Aim: To quantitatively assess whether SIVAC support is associated with a faster rate at which NITAGs became functional based on six performance indicators. Methods: Data from the World Health Organization/Unicef Joint Reporting Form (JRF) from 77 low and lower-middle-income countries were used to examine the time delay between the start of SIVAC support and NITAG functionality using a Cox proportional hazards model. Results: Countries receiving SIVAC support took a mean of 2.00 (95% CI 1.40–2.60) years to reported functionality compared to 2.82 (95% CI 2.05–3.59) years for countries without SIVAC support. We found evidence that SIVAC support is associated with reduced time until NITAG functionality, and this association cannot fully be explained by GDP per capita, percentage of GDP spent on healthcare, or NITAG functionality score at the start of the study period. However, quality of JRF data for the questions used to calculate NITAG functionality were poor, particularly for countries not receiving SIVAC support. Conclusion: SIVAC support is likely to have enabled many countries to more rapidly achieve NITAG functionality.
AB - Background: National Immunisation Technical Advisory Groups (NITAGs) are multi-disciplinary expert groups that provide policy-makers with independent, evidence-based advice on vaccination. Between 2008 and 2017, the SIVAC Initiative supported establishment and strengthening of NITAGs in low and lower-middle income countries though its impact was never assessed quantitatively. Aim: To quantitatively assess whether SIVAC support is associated with a faster rate at which NITAGs became functional based on six performance indicators. Methods: Data from the World Health Organization/Unicef Joint Reporting Form (JRF) from 77 low and lower-middle-income countries were used to examine the time delay between the start of SIVAC support and NITAG functionality using a Cox proportional hazards model. Results: Countries receiving SIVAC support took a mean of 2.00 (95% CI 1.40–2.60) years to reported functionality compared to 2.82 (95% CI 2.05–3.59) years for countries without SIVAC support. We found evidence that SIVAC support is associated with reduced time until NITAG functionality, and this association cannot fully be explained by GDP per capita, percentage of GDP spent on healthcare, or NITAG functionality score at the start of the study period. However, quality of JRF data for the questions used to calculate NITAG functionality were poor, particularly for countries not receiving SIVAC support. Conclusion: SIVAC support is likely to have enabled many countries to more rapidly achieve NITAG functionality.
KW - Low and middle-income countries
KW - NITAG
KW - SIVAC
KW - Vaccination
KW - Vaccine policy
UR - http://www.scopus.com/inward/record.url?scp=85057976843&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85057976843&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2018.11.070
DO - 10.1016/j.vaccine.2018.11.070
M3 - Article
C2 - 30545715
AN - SCOPUS:85057976843
SN - 0264-410X
VL - 37
SP - 430
EP - 434
JO - Vaccine
JF - Vaccine
IS - 3
ER -